Snowden Capital Advisors’s Fulgent Genetics FLGT Stock Holding History

Snowden Capital Advisors’s Portfolio FLGT Stock Details FLGT Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q3	–	Sell	-19,821	Closed	-$734K	–	1098
2023 Q2	$734K	Sell	19,821 -268	-1%	-$9.34K	0.03%	565
2023 Q1	$627K	Sell	20,089 -378	-2%	-$12.2K	0.02%	631
2022 Q4	$610K	Sell	20,467 -1,745	-8%	-$62.4K	0.03%	624
2022 Q3	$846K	Buy	22,212 +519	+2%	+$26K	0.04%	456
2022 Q2	$1.18M	Buy	21,693 +178	+0.8%	+$9.78K	0.05%	377
2022 Q1	$1.34M	Buy	21,515 +18,865	+712%	+$1.24M	0.05%	354
2021 Q4	$266K	Sell	2,650 -1,330	-33%	-$117K	0.01%	602
2021 Q3	$358K	Buy	3,980 +110	+3%	+$10K	0.02%	627
2021 Q2	$357K	Sell	3,870 -50	-1%	-$3.99K	0.02%	647
2021 Q1	$379K	Sell	3,920 -260	-6%	-$26.8K	0.02%	559
2020 Q4	$218K	Buy	+4,180	New	+$175K	0.01%	613

Other funds holding FLGT

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

DSCM

Divisadero Street Capital Management Miami, Florida $2.39B AUM 134.55% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

PWAM

Park West Asset Management San Francisco, California $1.18B AUM 47.25% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Nuveen Charlotte, North Carolina $369B AUM 31.66% 1-Year Est. Return

Snowden Capital Advisors's FLGT Position: Q3 2023 in Review

Snowden Capital Advisors sold out of Fulgent Genetics (FLGT) in Q3 2023, closing a stake of 19,821 shares — an estimated $734K sold.

Snowden Capital Advisors first reported a position in FLGT in Q4 2020 and held it in 11 quarters. The position peaked at $1.34M in Q1 2022. 201 funds tracked by Wall St. Rank hold FLGT as of Q3 2023.

Snowden Capital Advisors reported no remaining Fulgent Genetics position as of Q3 2023 after selling out during the quarter.
Snowden Capital Advisors sold 19,821 Fulgent Genetics shares in Q3 2023, an estimated $734K.
Snowden Capital Advisors first reported a position in Fulgent Genetics in Q4 2020 and held it in 11 quarters.
Snowden Capital Advisors's Fulgent Genetics position peaked at $1.34M in Q1 2022.
201 funds tracked by Wall St. Rank held Fulgent Genetics as of Q3 2023.

Based on Snowden Capital Advisors's 13F filing for Q3 2023, filed 14 Nov 2023.